The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Truoxin I.V. 400 mg/200 ml solution for infusion

Hikma Farmacêutica (Portugal) S.A.PA1217/002/002

Main Information

Trade NameTruoxin I.V. 400 mg/200 ml solution for infusion
Active SubstancesCiprofloxacin
Dosage FormSolution for infusion
Licence HolderHikma Farmacêutica (Portugal) S.A.
Licence NumberPA1217/002/002

Group Information

ATC CodeJ01MA Fluoroquinolones
J01MA02 ciprofloxacin


License statusAuthorised
Licence Issued11/04/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back